[1]
|
Ford, A.C., Moayyedi, P., Chey, W.D., et al. (2018) American College of Gastroenterology Monograph on Management of Irritable Bowel Syndrome. American Journal of Gastroenterology, 113, 1-18.
https://doi.org/10.1038/s41395-018-0084-x
|
[2]
|
Ford, A.C., Sperber, A.D., Corsetti, M. and Camilleri, M. (2020) Irritable Bowel Syndrome. The Lancet, 396, 1675-1688.
https://doi.org/10.1016/S0140-6736(20)31548-8
|
[3]
|
Camilleri, M., Zhernakova, A., Bozzarelli, I. and D’Amato, M. (2022) Genetics of Irritable Bowel Syndrome: Shifting Gear via Biobank-Scale Studies. Nature Reviews Gastroen-terology & Hepatology, 19, 689-702.
https://doi.org/10.1038/s41575-022-00662-2
|
[4]
|
Black, C.J. and Ford, A.C. (2020) Global Burden of Irritable Bowel Syndrome: Trends, Predictions and Risk Factors. Nature Reviews Gastroenterology & Hepatology, 17, 473-486. https://doi.org/10.1038/s41575-020-0286-8
|
[5]
|
Aguilera-Lizarraga, J., Hussein, H. and Boeckxstaens, G.E. (2022) Immune Activation in Irritable Bowel Syndrome: What Is the Evidence? Nature Reviews Immunology, 22, 674-686. https://doi.org/10.1038/s41577-022-00700-9
|
[6]
|
Vasant, D.H., Paine, P.A., Black, C.J., et al. (2021) British So-ciety of Gastroenterology Guidelines on the Management of Irritable Bowel Syndrome. Gut, 70, 1214-1240. https://doi.org/10.1136/gutjnl-2021-324598
|
[7]
|
Ghoshal, U. C., Nehra, A., Mathur, A., and Rai, S. (2020) A Me-ta-Analysis on Small Intestinal Bacterial Overgrowth in Patients with Different Subtypes of Irritable Bowel Syndrome. Journal of Gastroenterology and Hepatology, 35, 922-931.
https://doi.org/10.1111/jgh.14938
|
[8]
|
Losurdo, G., D’Abramo, F., Indellicati, G., et al. (2020) The Influence of Small Intestinal Bacterial Overgrowth in Digestive and Extra-Intestinal Disorders. International Journal of Molecular Sciences, 21, Article No. 3531.
https://doi.org/10.3390/ijms21103531
|
[9]
|
Wijarnpreecha, K., Werlang, M.E., Watthanasuntorn, K., Panjawatanan, P., Cheungpasitporn, W., Gomez, V., Lukens, F.J. and Ungprasert, P. (2020) Obesity and Risk of Small Intestine Bacte-rial Overgrowth: A Systematic Review and Meta-Analysis. Digestive Diseases and Sciences, 65, 1414-1422. https://doi.org/10.1007/s10620-019-05887-x
|
[10]
|
Pimentel, M., Saad, R.J., Long, M.D. and Rao, S. (2020) ACG Clinical Guideline Small Intestinal Bacterial Overgrowth. The American Journal of Gastroenterology, 115, 165-178. https://doi.org/10.14309/ajg.0000000000000501
|
[11]
|
Takakura, W. and Pimentel, M. (2020) Small Intestinal Bac-terial Overgrowth and Irritable Bowel Syndrome—An Update. Frontiers in Psychiatry, 11, Article 664. https://doi.org/10.3389/fpsyt.2020.00664
|
[12]
|
Chen, B., Kim, J.J.-W., Zhang, Y., Du, L. and Dai, N. (2018) Prev-alence and Predictors of Small Intestinal Bacterial Overgrowth in Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis. Journal of Gastroenterology, 53, 807-818. https://doi.org/10.1007/s00535-018-1476-9
|
[13]
|
Wu, K.-Q., Sun, W.-J., Li, N., et al. (2019) Small Intestinal Bacterial Overgrowth Is Associated with Diarrhea-Predominant Irritable Bowel Syndrome by Increasing Mainly Prevotella Abundance. Scandinavian Journal of Gastroenterology, 54, 1419-1425. https://doi.org/10.1080/00365521.2019.1694067
|
[14]
|
Gandhi, A., Shah, A., Jones, M.P., et al. (2021) Methane Positive Small Intestinal Bacterial Overgrowth in Inflammatory Bowel Disease and Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis. Gut Microbes, 13, Article 1933313. https://doi.org/10.1080/19490976.2021.1933313
|
[15]
|
Yang, M., Zhang, L., Hong, G., et al. (2020) Duodenal and Rectal Mucosal Microbiota Related to Small Intestinal Bacterial Overgrowth in Diarrhea-Predominant Irritable Bowel Syndrome. Journal of Gastroenterology and Hepatology, 35, 795-805. https://doi.org/10.1111/jgh.14910
|
[16]
|
Burns, G.L., Talley, N.J. and Keely, S. (2022) Immune Responses in the Ir-ritable Bowel Syndromes: Time to Consider the Small Intestine. BMC Medicine, 20, Article No. 115. https://doi.org/10.1186/s12916-022-02301-8
|
[17]
|
Singh, P. and Lembo, A. (2021) Emerging Role of the Gut Mi-crobiome in Irritable Bowel Syndrome. Gastroenterology Clinics of North America, 50, 523-545. https://doi.org/10.1016/j.gtc.2021.03.003
|
[18]
|
Shah, A., Talley, N.J., Jones, M., et al. (2020) Small Intestinal Bac-terial Overgrowth in Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Case-Control Studies. The American Journal of Gastroenterology, 115, 190-201.
https://doi.org/10.14309/ajg.0000000000000504
|
[19]
|
Ding, X.W., Liu, Y.X., Fang, X.C., et al. (2017) The Rela-tionship between Small Intestinal Bacterial Overgrowth and Irritable Bowel Syndrome. European Review for Medical and Pharmacological Sciences, 21, 5191-5196.
|
[20]
|
Lee, S.-H., Joo, N.-S., Kim, K.-M. and Kim, K.-N. (2018) The Thera-peutic Effect of a Multistrain Probiotic on Diarrhea-Predominant Irritable Bowel Syndrome: A Pilot Study. Gastroenter-ology Research and Practice, 2018, Article ID: 8791916. https://doi.org/10.1155/2018/8791916
|
[21]
|
Stefanolo, J.P., Tevez, A., Manresa, M.M., et al. (2019) Therapeutic Response to Small Intestinal Bacterial Overgrowth (SIBO) in Irritable Bowel Syndrome (IBS). Is It Useful to Test For? Gastroenterology, 156, S-190-S-191.
https://doi.org/10.1016/S0016-5085(19)37267-1
|
[22]
|
Gu, P., Patel, D., Lakhoo, K., et al. (2020) Breath Test Gas Patterns in Inflammatory Bowel Disease with Concomitant Irritable Bowel Syndrome-Like Symptoms: A Controlled Large-Scale Database Linkage Analysis. Digestive Diseases and Sciences, 65, 2388-2396. https://doi.org/10.1007/s10620-019-05967-y
|
[23]
|
Lee, S.-H., Cho, D.-Y., Joo, N.-S. and Kim, K.-N. (2019) Effect of Eradicating Hydrogen-Forming Small Intestinal Bacterial Overgrowth with Rifaximin on Body Weight Change. Medi-cine, 98, e18396.
https://doi.org/10.1097/MD.0000000000018396
|
[24]
|
Zhuang, X., Tian, Z., Luo, M. and Xiong, L. (2020) Short-Course Rifaximin Therapy Efficacy and Lactulose Hydrogen Breath Test in Chinese Patients with Diar-rhea-Predominant Irritable Bowel Syndrome. BMC Gastroenterology, 20, Article No. 187. https://doi.org/10.1186/s12876-020-01336-6
|
[25]
|
Tuteja, A.K., Talley, N.J., Stoddard, G.J. and Verne, G.N. (2019) Double-Blind Placebo-Controlled Study of Rifaximin and Lactulose Hydrogen Breath Test in Gulf War Veterans with Ir-ritable Bowel Syndrome. Digestive Diseases and Sciences, 64, 838-845. https://doi.org/10.1007/s10620-018-5344-5
|
[26]
|
Leventogiannis, K., Gkolfakis, P., Spithakis, G., et al. (2018) Ef-fect of a Preparation of Four Probiotics on Symptoms of Patients with Irritable Bowel Syndrome: Association with Intes-tinal Bacterial Overgrowth. Probiotics and Antimicrobial Proteins, 11, 627-634. https://doi.org/10.1007/s12602-018-9401-3
|
[27]
|
Su, T., Lai, S., Lee, A., He, X. and Chen, S. (2017) Me-ta-Analysis: Proton Pump Inhibitors Moderately Increase the Risk of Small Intestinal Bacterial Overgrowth. Journal of Gastroenterology, 53, 27-36.
https://doi.org/10.1007/s00535-017-1371-9
|
[28]
|
Schmulson, M.J. and Frati-Munari, A.C. (2019) Síntomas intestinales en pacientes que reciben inhibidores de bomba de protones (IBP). Resultados de una encuesta multicéntrica en México. Revista de Gastroenterología de México, 84, 44-51. https://doi.org/10.1016/j.rgmx.2018.02.008
|
[29]
|
Wielgosz-Grochowska, J.P., Domanski, N. and Drywien, M.E. (2022) Efficacy of an Irritable Bowel Syndrome Diet in the Treatment of Small Intestinal Bacterial Overgrowth: A Narra-tive Review. Nutrients, 14, Article No. 3382.
https://doi.org/10.3390/nu14163382
|
[30]
|
Wright, C., Dooley, M. and Leeson, H. (2021) Eradication of Small In-testinal Bacterial Overgrowth in Irritable Bowel Syndrome Using Herbal Therapy: A Case Report. International Journal of Functional Nutrition, 2, Article No. 13.
https://doi.org/10.3892/ijfn.2021.23
|